# Persistent Readiness Through Early Prediction Immunization Study

> **NCT05346302** · EARLY_PHASE1 · COMPLETED · sponsor: **Texas A&M University** · enrollment: 249 (actual)

## Conditions studied

- Inflammatory Response

## Interventions

- **DRUG:** Pneumovax 23
- **DRUG:** Typhim VI
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT05346302
- **Lead sponsor:** Texas A&M University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-08
- **Primary completion:** 2022-12-21
- **Final completion:** 2022-12-21
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2023-02-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05346302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05346302, "Persistent Readiness Through Early Prediction Immunization Study". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05346302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*